Patient Reported Outcome After Surgical Treatment of DDD in Scandinavia
NCT ID: NCT02980822
Last Updated: 2024-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3500 participants
OBSERVATIONAL
2011-01-01
2019-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypotheses: (i) there are no differences in patient-reported outcome after surgery between these countries, (ii) there are no differences in indications for surgery between these countries and (iii), factors that predict outcome are similar in these countries.
Method of research: By using data from three Nordic national spine registers, investigators will compare baseline data, indications for surgery and patient reported outcome one year after surgery for lumbar disc decease. Register based studies have advantages such as large sample sizes, reflecting real life, but they also have limitations such as lower follow-up rates than clinical trials. A non-response analysis will be performed to take this into account.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcome of Surgery for Sciatica - a Comparison of Data From Three National Quality Registries
NCT02889484
The NORDSTEN Study - Degenerative Spondylolisthesis
NCT02051374
Outcome of Surgery for Lumbar Spinal Stenosis - a Comparison of Data From Three National Quality Registries
NCT02897947
The Use of a Patient Decision Aid in the Choice of Surgery for Herniated Disc
NCT03884387
Neurosurgery Patient Outcomes in Treating Spinal Disorders
NCT01220921
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The registers
All registries have the aim of studying outcome after spine surgery. All departments and patients participate voluntarily. At the time of admission, the patient reports data consisting of information on social factors, comorbidity and previous surgery. After surgery, the surgeon records diagnosis and type of surgery performed.
The Swespine Register has included individuals treated with surgery for DDD since 1993. During the last decade, the number of departments participating in the registry has varied between 35 and 41 of the 42 to 45 departments providing spinal surgery services in Sweden. Coverage is approximately 90%. The completeness (number of patients reported to Swespine at the time of surgery) is approximately 80%.
The Norwegian Spine register, NORspine, is based on experiences from the Swespine register and previous validation studies from a local clinical registry, and was founded in 2007. In total 36 of 40 centers performing lumbar spine surgery in Norway report to NORspine. Coverage is approximately 90%. The completeness is approximately 65%.
The Danish spine register, DaneSpine, is based on Swespine and was acquired by the Danish Spine Society from the Swedish Society of Spinal Surgeons in 2009 and has successively been implemented. In total 17 of 19 centers performing lumbar spine surgery in Denmark report to DaneSpine. Coverage is approximately 90%. The completeness is approximately 60%.
Quality assurance As for all studies, there is a risk that loss to follow-up may bias the results. Solberg et al. (2011) studied 633 patients, who were operated on for degenerative disorders of the lumbar spine in Norway, and found that a loss to follow-up of 22% would not bias conclusions about overall treatment effects. There were no indications of worse outcomes in the non-responders group. In a similar one-center study of the DaneSpine. Højmark et al. (2016) found that a loss to follow-up of 12% at did not seem to bias the conclusions that can be drawn from DaneSpine at that center. Preliminary data indicates that predictors of outcome after lumbar disc herniation surgery are comparable with data in a study with a very high follow-up rate and with the Swespine register.
Data handling
Anonymized individual level data from all three registers will be pooled in one database. The cohort will be divided by country for comparisons.
Missing data and out of range data
In case of missing data case exclusion analysis by analysis, will be used. Out of range data will be deleted.
Analysis
The data will be cleaned by excluding patients with missing or incorrect date of surgery, missing date for follow-up, previous lumbar spine surgery and surgery other than discectomy only.
After data cleaning, we aim to perform blinded statistical analyses, in which the independent statistician performing the analyses is unaware of group belonging (i.e. country). The code will not be broken until the analyses and interpretations have been performed.
Comparisons of indications for surgery
Analysis of baseline data will include age at surgery, sex, anthropometrics, number of smokers, Oswestry Disability Index, numeric rating scale leg pain, numeric rating scale back pain, EQ-5D, number on sick leave, employment status, and duration of leg and back pain and presented as mean (SD), mean (95% confidence interval), or number (%).
Variables will be analyzed by analysis of variance, Chi-square or logistic regression tests. Data will be presented as crude (unadjusted) data to elucidate any differences between the countries.
Comparisons of outcome
Comparisons of the change of the outcome variables from baseline to 1 year, as well as comparisons of the actual value at 1 year will be performed. Analysis of covariance, Chi-square or logistic regression tests and the crude (unadjusted) data will be presented.
In addition, baseline variables will be used as covariates in the analysis of covariance and the adjusted data presented.
Non-response analysis A non-response analysis will be performed comparing all available baseline variables between those that responded to the 1 year follow-up with those that did not respond.
Sample size
A study of similar character has never been performed before. Due to the nature of the study, the sample size is not formulated in the guise of power, risk level, or clinical difference. The number of patients participating in the study is estimated to 3500. The sample is so large that differences in the Oswestry Disability Index of as low as 2 points may be detected (power 90%, significance level 5%), but in the interpretation the minimal important difference of 10-15 points in the Oswestry Disability Index often referred to has to be taken into account.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sweden, Denmark, Norway
Group: Degenerative lumbar disc disease patients treated in Sweden and included in the Swespine register
Group: Degenerative lumbar disc disease patients treated in Norway and included in the NORspine register
Group: Degenerative lumbar disc disease patients treated in Denmark and included in the DaneSpine register
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Spine Centre of Southern Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karen Højmark Hansen
Research Nurse, Head of the national DaneSpine office
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mikkel Ø Andersen, MD
Role: PRINCIPAL_INVESTIGATOR
Sygehus Lilleaelt
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DKMiddelfart4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.